Removing Regulatory Roadblocks
Expediting Market Access
> Which testing method is adopted for adsorption/desorption test?
> For mixtures, how to calculate LD50?
> Is it acceptable to use in vitro mammalian cell micronucleus test (OECD TG 487) instead of in vitro chromosome aberration test (OECD TG 473)?
> Is it acceptable to use combined chronic toxicity and carcinogenicity test (OECD TG 453) instead of carcinogenicity test (OECD TG 451) and chronic toxicity test (OECD TG 452)?
> Is it acceptable to use bovine corneal opacity and permeability test (OECD TG 437) or isolated chicken eye test (OECD TG 438) instead of eye irritation/corrosion (OECD TG 405)?
> Is it acceptable to submit in vitro skin irritation data (OECD TG 439) instead of acute dermal irritation/corrosion data (OECD TG 404)？
Company A and B are both foreign companies. Company A has obtained the registration certificate of the new chemical substance P. Company A will sell substance P to company B, and B will re-sell it to company C. Does company C need to obtain the registration certificate?
We have a product reagent in small bottles wrapped by outer boxes. How should we label it in this case?
How to determine the hazard classification of mixtures?
What chemicals need to be registered?
If the new chemical substances has already been notified under SEPA Order 17 (predecessor of MEP Order 7), is it necessary to comply with the scientific research record notification under MEP Order 7?
ChemLinked Chemical Portal was created to provide chemical regulatory information for China and
the rest of the Asia Pacific region to meet the growing demand for clear and concise regulatory
advice and market intelligence.
ChemLinked is based in China, our office hour is 9:00 - 17:30 GMT+8 Beijing time.
Skype: ChemLinked Official
Phone: +86 (0) 571 8710 3812
© 2012-2017 ChemLinked
Term of Use